4.7 Article

Characteristics of children diagnosed with type 1 diabetes before vs after 6 years of age in the TEDDY cohort study

期刊

DIABETOLOGIA
卷 64, 期 10, 页码 2247-2257

出版社

SPRINGER
DOI: 10.1007/s00125-021-05514-3

关键词

Autoimmunity; Type 1 diabetes

资金

  1. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01 DK63829, U01 DK63861, U01 DK63821, U01 DK63865, U01 DK63863, U01 DK63836, U01 DK63790, UC4 DK63829, UC4 DK63861, UC4 DK63821, UC4 DK63865, UC4 DK63863, UC4 DK63836, UC4 DK95300, UC4 DK100238, UC4 DK106955, UC4 DK112243, UC4 DK117483, U01 DK124166, HHSN267200700014C]
  2. National Institute of Allergy and Infectious Diseases (NIAID)
  3. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  4. National Institute of Environmental Health Sciences (NIEHS)
  5. JDRF
  6. Centers for Disease Control and Prevention (CDC)
  7. NIH/NCATS Clinical and Translational Science Awards [UL1 TR000064, UL1 TR002535]

向作者/读者索取更多资源

Children diagnosed with type 1 diabetes before the age of 6 tend to develop autoantibodies earlier and progress to diabetes more rapidly compared to those diagnosed between 6-13 years of age. The diabetes risk associated with HLA genotypes is significant in older children, while for younger children, the country of origin was a significant factor. Early onset diabetes is likely preceded by IAA autoantibodies and is more aggressive, while in older children, the progression to diabetes does not seem to be influenced by age or family history once multiple autoantibodies are present.
Aims/hypothesis Prognostic factors and characteristics of children diagnosed with type 1 diabetes before 6 years of age were compared with those diagnosed at 6-13 years of age in the TEDDY study. Methods Genetically high-risk children (n = 8502) were followed from birth for a median of 9.9 years; 328 (3.9%) were diagnosed with type 1 diabetes. Cox proportional hazard model was used to assess the association of prognostic factors with the risk of type 1 diabetes in the two age groups. Results Children in the younger group tended to develop autoantibodies earlier than those in the older group did (mean age 1.5 vs 3.5 years), especially insulin autoantibodies (IAA), which developed earlier than GAD autoantibodies (GADA). Children in the younger group also progressed to diabetes more rapidly than the children in the older group did (mean duration 1.9 vs 5.4 years). Children with autoantibodies first appearing against insulinoma antigen-2 (IA-2A) were found only in the older group. The significant diabetes risk associated with the country of origin in the younger group was no longer significant in the older group. Conversely, the diabetes risk associated with HLA genotypes was statistically significant also in the older group. Initial seroconversion after and before 2 years of age was associated with decreased risk for diabetes diagnosis in children positive for multiple autoantibodies, but the diabetes risk did not decrease further with increasing age if initial seroconversion occurred after age 2. Diabetes risk associated with the minor alleles of rs1004446 (INS) was decreased in both the younger and older groups compared with other genotypes (HR 0.67). Diabetes risk was significantly increased with the minor alleles of rs2476601 (PTPN22) (HR 2.04 and 1.72), rs428595 (PPIL2) (HR 2.13 and 2.10), rs113306148 (PLEKHA1) (HR 2.34 and 2.21) and rs73043122 (RNASET2) (HR 2.31 and 2.54) (HR values represent the younger and older groups, respectively). Conclusions/interpretations Diabetes at an early age is likely to be preceded by IAA autoantibodies and is a more aggressive form of the disease. Among older children, once multiple autoantibodies have been observed there does not seem to be any association between progression to diabetes and the age of the child or family history. Graphical abstract

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据